| AstraZeneca AG - Fluenz Tetra, Nasenspray, Suspension | | 68462 | | 01 | | Fluenz Tetra | | Nasenspray, Suspension | | J07BB03 | | Influenza, Live Attenuated | | 11.05.2022 | | |
| | Composition | | virus influenzae A (H1N1) vivus attenuatum (Virus-Stamm A/Victoria/2570/2019 (H1N1)pdm09-like strain (A/Victoria/1/2020, MEDI 340505)) 70 Mio. FFU, virus influenzae A (H3N2) vivus attenuatum (Virus-Stamm A/Darwin/9/2021 (H3N2)-like A/Norway/16606/2021 (MEDI 355293)) 70 Mio. FFU, virus influenzae B vivus attenuatum (Virus-Stamm B/Austria/1359417/2021-like B/Austria/1359417/2021 (MEDI 355293, Victoria lineage)) 70 Mio. FFU, virus influenzae B vivus attenuatum (Virus-Stamm B/Phuket/3073/2013-like: B/Phuket/3073/2013 (MEDI 306444, Yamagata lineage)) 70 Mio. FFU, saccharum, dikalii phosphas anhydricus, kalii dihydrogenophosphas, gelatina hydrolysata, arginini hydrochloridum, natrii hydrogenoglutamas monohydricus, aqua ad iniectabile q.s. ad suspensionem pro 0.2 ml. | | Packungsbestandteile | | Spray nasale | | | | | | Principe actif | Concentr. |
|---|
| Virus Influenzae a (H1N1) Vivus Attenuatum (Virus-Stamm A/victoria/2570/2019 (H1N1)pdm09-Like Strain (A/victoria/1/2020, medi 340505)) | 70 | | Virus Influenzae a (H3N2) Vivus Attenuatum (Virus-Stamm A/darwin/9/2021 (H3N2)-Like A/norway/16606/2021 (Medi 355293)) | 70 | | Virus Influenzae b Vivus Attenuatum (Virus-Stamm B/austria/1359417/2021-Like B/austria/1359417/2021 (Medi 355293, Victoria Lineage)) | 70 |
| | | | Agents auxilliaires | Concentr. |
|---|
| Arginine Hydrochloride | | | Dipotassium Phosphate Anhydre | | | Gelatina Hydrolysata | | | Potassium Dihydrogenophosphate | | | Mio. Ffu | | | Natrii Hydrogenoglutamas Monohydricus | | | Saccharum | | | Virus Influenzae b Vivus Attenuatum (Virus-Stamm B/phuket/3073/2013-Like: B/phuket/3073/2013 (Medi 306444, Yamagata Lineage)) | 70 |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| Aucune entrée n'a été trouvée. |
|
|
